- Q1 2024 BioNTech SE Earnings Call TranscriptMay 06, 2024$93.35 (+0.68%)Earnings
- Q4 2023 BioNTech SE Earnings Call TranscriptMar 20, 2024$90 (-4.38%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- BioNTech SE Inaugurates its First African Site in Kigali TranscriptDec 18, 2023
- BioNTech SE Capital Markets Day TranscriptNov 07, 2023
- Q3 2023 BioNTech SE Earnings Call TranscriptNov 06, 2023$99.71 (+4.10%)Earnings
- Q2 2023 BioNTech SE Earnings Call TranscriptAug 07, 2023$98.5 (-7.49%)Earnings
- Q1 2023 BioNTech SE Earnings Call TranscriptMay 08, 2023$108.05 (-0.35%)Earnings
- Q4 2022 BioNTech SE Earnings Call TranscriptMar 27, 2023$123.6 (-3.59%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 BioNTech SE Earnings Call TranscriptNov 07, 2022$160.72 (+4.15%)Earnings
- Q2 2022 BioNTech SE Earnings Call TranscriptAug 08, 2022$169.3 (-7.54%)Earnings
- BioNTech SE To Discuss on Host First Edition of Innovation Series on Diversified Pipeline, Latest Technology Innovations Call TranscriptJun 29, 2022
- Q1 2022 BioNTech SE Earnings Call TranscriptMay 09, 2022$140.32 (+3.05%)Earnings
- Q4 2021 BioNTech SE Earnings Call TranscriptMar 30, 2022$174.78 (+1.39%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 11, 2022
- BioNTech SE To Discuss Hold Digital Press Conference to Provide an Update on Omicron Variant Call TranscriptDec 08, 2021
- Q3 2021 BioNTech SE Earnings Call TranscriptNov 09, 2021$226.37 (-6.69%)Earnings
- Q2 2021 BioNTech SE Earnings Call TranscriptAug 09, 2021$447.23 (+14.97%)Earnings
- BioNTech SE at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- BioNTech SE at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- BioNTech SE at UBS Global Healthcare Virtual Conference TranscriptMay 26, 2021
- Q1 2021 BioNTech SE Earnings Call TranscriptMay 10, 2021$202.35 (+10.15%)Earnings
- BioNTech SE at JPMorgan NAPA Valley Forum (Virtual) TranscriptMar 31, 2021
- Q4 2020 BioNTech SE Earnings Call TranscriptMar 30, 2021$104.44 (+8.89%)Earnings
- BioNTech SE at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 24, 2021
- BioNTech SE at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 BioNTech SE Earnings Call TranscriptNov 10, 2020$112.76 (+7.60%)Earnings
- Q2 2020 BioNTech SE Earnings Call TranscriptAug 11, 2020$68.45 (-7.44%)Earnings
- BioNTech SE To Present Early Positive Data From Ongoing Phase 1/2 Study of mRNA-Based Vaccine Candidate Against SARS-CoV-2 Call TranscriptJul 01, 2020
- BioNTech SE at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- BioNTech SE at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 BioNTech SE Earnings Call TranscriptMay 12, 2020$49.33 (-1.30%)Earnings
- BioNTech SE - Special Call TranscriptApr 23, 2020
- Full Year 2019 BioNTech SE Earnings Call TranscriptMar 31, 2020$58.4 (-5.81%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 BioNTech SE Earnings Call TranscriptNov 14, 2019$19 (+2.43%)Earnings
Q1 2022 BioNTech SE Earnings Call Transcript
Welcome to the BioNTech First Quarter 2022 Update Call. I would like to hand the call over to the Vice President of Investor Relations and Strategy, Sylke Maas. Please go ahead, Sylke.
Good morning and good afternoon, and thank you for joining us today to review BioNTech's First Quarter 2022 Clinical and Operational Progress and Financial Results. A few housekeeping items before we start. Please view the slides that accompany the webcast in the first quarter 2022 press release, both were issued this morning and can be found in the Investors section of our website.
As outlined on Slide 2, today's presentation, we'll be making several forward-looking statements. These forward-looking statements include, but are not limited to, our current COVID-19 vaccine revenues as they include figures that are derived from preliminary estimates provided by our partners, our estimated financial results for 2022, the continued global demand for our COVID-19 vaccine, our target vaccine production capacity for 2022
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)